WHO ICTRP trial
Regenerative cell therapy of ex vivo expanded autologous peripheral mononuclear…
JPRN-UMIN000016665 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000016665 |
|---|---|
| Public title | Regenerative cell therapy of ex vivo expanded autologous peripheral mononuclear cells for patients with non-healing wound -phase I study- |
| Scientific title | Regenerative cell therapy of ex vivo expanded autologous peripheral mononuclear cells for patients with non-healing wound -phase I study- - Regenerative cell therapy of ex vivo expanded autologous peripheral mononuclear cells for patients with non-healing wound -phase I study- |
| Primary sponsor | Juntendo University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | non-healing wound |
| Interventions | Ex vivo expanded autologous peripheral mononuclear cells, 2 x 10^7 cells,within 20sites surround 20cm around the wound. subcutaneous or intramuscular injection |
| Registration date | Apr 3, 2015 |
| Target size | 10 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: